Linear Diagnostics
Linear Diagnostics Limited is dedicated to delivering enhanced diagnostic solutions through novel technology, focusing on rapid, accurate, and cost-effective point-of-care testing for infectious diseases, especially sexually transmitted infections. The company utilizes proprietary linear dichroism and EXPAR technologies to enable rapid detection of multiple targets with disposable cartridges on low-cost instruments, aiming to improve healthcare outcomes and reduce costs.
Industries
Nr. of Employees
small (1-50)
Linear Diagnostics
Birmingham, Birmingham, United Kingdom, Europe
Products
Dual nucleic-acid rapid point-of-care test for chlamydia and gonorrhoea
A duplex nucleic-acid test designed to detect gene sequences specific to Chlamydia trachomatis and Neisseria gonorrhoeae from a single sample, providing a rapid time-to-result (~15–20 minutes) using a disposable cartridge and portable reader to enable same-visit diagnosis and treatment.
Rapid SARS‑CoV‑2 IgM/IgG antibody test with compact reader and digital certificate
A 15‑minute point-of-care antibody test that provides separate IgM and IgG results from finger‑stick whole blood, uses a compact reader to provide quantified results (Negative/Weak/Moderate/Strong) and stores a digital antibody certificate on a smartphone.
Rapid SARS‑CoV‑2 antigen nasal-swab test
A minimally invasive nasal-swab antigen test with a ~20 minute time-to-result and reported performance against known variants.
Portfolio of rapid POC tests for infectious diseases (HIV, syphilis, Zika, Ebola)
A set of rapid point-of-care tests for various infectious diseases offered via distribution agreements.
Dual nucleic-acid rapid point-of-care test for chlamydia and gonorrhoea
A duplex nucleic-acid test designed to detect gene sequences specific to Chlamydia trachomatis and Neisseria gonorrhoeae from a single sample, providing a rapid time-to-result (~15–20 minutes) using a disposable cartridge and portable reader to enable same-visit diagnosis and treatment.
Rapid SARS‑CoV‑2 IgM/IgG antibody test with compact reader and digital certificate
A 15‑minute point-of-care antibody test that provides separate IgM and IgG results from finger‑stick whole blood, uses a compact reader to provide quantified results (Negative/Weak/Moderate/Strong) and stores a digital antibody certificate on a smartphone.
Rapid SARS‑CoV‑2 antigen nasal-swab test
A minimally invasive nasal-swab antigen test with a ~20 minute time-to-result and reported performance against known variants.
Portfolio of rapid POC tests for infectious diseases (HIV, syphilis, Zika, Ebola)
A set of rapid point-of-care tests for various infectious diseases offered via distribution agreements.
Services
Co-development partnerships for point-of-care diagnostic devices
Collaborative development relationships to co-develop disposable cartridges and portable reader hardware for near-patient tests.
Regional distribution of rapid POC infectious disease tests
Distribution and customer support for CE‑IVD rapid antigen and antibody tests including SARS-CoV-2 assays in specified territories.
R&D and platform engineering for POC assays and hardware
Research and development services to translate detection chemistry into disposable cartridges and compact reader instruments suitable for point-of-care deployment.
Co-development partnerships for point-of-care diagnostic devices
Collaborative development relationships to co-develop disposable cartridges and portable reader hardware for near-patient tests.
Regional distribution of rapid POC infectious disease tests
Distribution and customer support for CE‑IVD rapid antigen and antibody tests including SARS-CoV-2 assays in specified territories.
R&D and platform engineering for POC assays and hardware
Research and development services to translate detection chemistry into disposable cartridges and compact reader instruments suitable for point-of-care deployment.
Expertise Areas
- Point-of-care diagnostic development
- Nucleic acid amplification assays (isothermal)
- Optical biosensor design using polarised light
- Multiplex assay design
Key Technologies
- Linear dichroism (polarised-light) detection
- EXPAR isothermal nucleic acid amplification
- Disposable self-sampling cartridge
- Visible‑dye based optical multiplexing